Blood Rush

MaxEstLa · 2025 · $14.49 · Action · deal grade D

• Estimated net residual revenue: $308 to $462 per month
• Opportunity: $385 per month at x1.00 dormancy
• Estimated lifetime owners: 5.1k
• 98%% positive across 171 reviews · 3.2 reviews/month

Why it's flagged

• Developer active, last post 0 months ago
• Last build shipped 0 months ago
• Last discounted 1 months ago, 7 sales in the last 12 months

This case as Markdown · Estimates carry ±30-50%% error per title.